Acro Biomedical (ACBM) Return on Assets (2016 - 2025)

Acro Biomedical has reported Return on Assets for 10 years, with the latest figure at 0.11% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets fell 10.0% year-over-year to 0.11%; the trailing twelve-month figure through Dec 2025 stood at 0.11% (down 10.0% YoY), and the FY2025 full-year result was 0.04%, down 3.0% from the prior year.
• Return on Assets for Q4 2025 stood at 0.11%, down from 0.05% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q1 2021, with the low at 2.27% in Q4 2023.
• Average Return on Assets over 5 years is 0.28%, with a median of 0.13% recorded in 2021.
• Year-over-year, Return on Assets sank 203 bps in 2023 and surged 226 bps in 2024.
• Tracing ACBM's Return on Assets over 5 years: stood at 0.11% in 2021, then tumbled by 116 bps to 0.24% in 2022, then plunged by 853 bps to 2.27% in 2023, then jumped by 99 bps to 0.01% in 2024, then tumbled by 817 bps to 0.11% in 2025.
• The last three Return on Assets figures came in at 0.11% (Q4 2025), 0.05% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.

Peer Comparison